A look at gene changes in MS, NMOSD, and MOGAD
Part of Brain & nervous system, Eyes & vision, Immune system & allergy clinical trials.
This study looks at a specific gene change in people with MS, NMOSD, or MOGAD to see how common it is. By joining, you help researchers learn more about these conditions and possible future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), or MOG antibody disease (MOGAD)
- You are being treated at one of the hospitals or clinics taking part in this study
- You can understand and sign a consent form agreeing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a registry study that collects health information from people with multiple sclerosis and related conditions. By joining, you help researchers better understand these diseases and improve future treatments.
This study looks at patients with neuromyelitis optica spectrum disorder (NMOSD)—a rare condition affecting the nervous system—who are doing well on rituximab treatment. Researchers want to understand hidden signs of disease activity that might predict future problems, even when patients feel stable.
This study builds a China-based group of people with neuroinflammatory and demyelination diseases and collects health and MRI (brain scan) information. It may help doctors better understand these conditions over time and improve future treatments.
This study follows people with certain inflammatory conditions of the brain and spinal cord (like MS, NMOSD, or MOGAD) to learn more about their disease. If you join, you will help researchers understand these conditions better.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This observational study follows people with various immune-related neurological conditions, such as multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. It aims to better understand these diseases and their progression over time.
Hear when a new MOGAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.